Literature DB >> 8187281

High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor.

G Murugesan1, G Sa, P L Fox.   

Abstract

Endothelial cell (EC) migration is a regulatory event in the formation and repair of blood vessels. Although serum contains substantial promigratory activity, the responsible components and especially the role of lipoproteins have not been determined. We examined the effect of plasma high-density lipoprotein (HDL) on the movement of ECs in vitro. Confluent cultures of bovine aortic ECs in serum-free medium were "wounded," and migration was measured after 24 hours. HDL stimulated migration in a concentration-dependent manner with a half-maximal response at 25 to 40 micrograms cholesterol per milliliter and a maximal twofold stimulation at approximately 150 micrograms cholesterol per milliliter. HDL-stimulated migration was not due to cell proliferation, since migration was increased in the presence of hydroxyurea at a concentration that blocked proliferation. At optimal concentrations, HDL was at least as stimulatory as basic fibroblast growth factor (FGF). However, the activity of HDL was not due to contamination by basic FGF, since antibodies to basic FGF did not block HDL-stimulated movement and since the maximum promigratory activities of basic FGF and HDL were additive. These results indicate that HDL and basic FGF may use distinct signaling pathways to initiate EC movement. This possibility was confirmed by results showing that pertussis toxin suppressed basic FGF-stimulated but not HDL-stimulated EC motility and that inhibitors of phospholipase A2, aristolochic acid and ONO-RS-082, also blocked the promigratory activity of basic FGF but had no effect on the activity of HDL.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1994        PMID: 8187281     DOI: 10.1161/01.res.74.6.1149

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

Review 1.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

Review 2.  Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

Authors:  Nosratola D Vaziri
Journal:  Kidney Int       Date:  2016-04-26       Impact factor: 10.612

Review 3.  Novel biological functions of high-density lipoprotein cholesterol.

Authors:  Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2012-09-28       Impact factor: 17.367

4.  Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein.

Authors:  G Murugesan; P L Fox
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  HDL and Endothelial Function.

Authors:  Yufei Wu; Yangkai Xu; Jie Chen; Mingming Zhao; Kerry-Anne Rye
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Antioxidant therapy reverses impaired graft healing in hypercholesterolemic rabbits.

Authors:  Michael A Rosenbaum; Keiko Miyazaki; Scott M Colles; Linda M Graham
Journal:  J Vasc Surg       Date:  2009-11-24       Impact factor: 4.268

Review 7.  Regulation of signal transduction by HDL.

Authors:  Chieko Mineo; Philip W Shaul
Journal:  J Lipid Res       Date:  2013-05-18       Impact factor: 5.922

8.  LXRβ/estrogen receptor-α signaling in lipid rafts preserves endothelial integrity.

Authors:  Tomonori Ishikawa; Ivan S Yuhanna; Junko Umetani; Wan-Ru Lee; Kenneth S Korach; Philip W Shaul; Michihisa Umetani
Journal:  J Clin Invest       Date:  2013-07-08       Impact factor: 14.808

9.  Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr192 and compromises its cardioprotective activity.

Authors:  Ilona Kareinen; Marc Baumann; Su Duy Nguyen; Katariina Maaninka; Andrey Anisimov; Minoru Tozuka; Matti Jauhiainen; Miriam Lee-Rueckert; Petri T Kovanen
Journal:  J Lipid Res       Date:  2018-03-26       Impact factor: 5.922

Review 10.  HDL abnormalities in nephrotic syndrome and chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.